Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD

• Published in: PLoS genetics Vol. 7; no. 9; p. e1002292
• Main Authors: Böger, Carsten A., Gorski, Mathias, Li, Man, Hoffmann, Michael M., Huang, Chunmei, Yang, Qiong, Teumer, Alexander, Krane, Vera, O'Seaghdha, Conall M., Kutalik, Zoltán, Wichmann, H.-Erich, Haak, Thomas, Boes, Eva, Coassin, Stefan, Coresh, Josef, Kollerits, Barbara, Haun, Margot, Paulweber, Bernhard, Köttgen, Anna, Li, Guo, Shlipak, Michael G., Powe, Neil, Hwang, Shih-Jen, Dehghan, Abbas, Rivadeneira, Fernando, Uitterlinden, André, Hofman, Albert, Beckmann, Jacques S., Krämer, Bernhard K., Witteman, Jacqueline, Bochud, Murielle, Siscovick, David, Rettig, Rainer, Kronenberg, Florian, Wanner, Christoph, Thadhani, Ravi I., Heid, Iris M., Fox, Caroline S., Kao, W. H.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.09.2011; Public Library of Science (PLoS)
• Subjects: Adaptor Proteins, Signal Transducing - genetics; Adult; Aged; Biology; Chronic Disease; Chronic kidney failure; Creatinine - blood; Diagnosis; Disease; Epidemiology; ErbB Receptors - genetics; Female; Follow-Up Studies; Genealogy; Genetic aspects; Genetic Association Studies; Genetics; Genomes; Glomerular filtration rate; Health aspects; Health sciences; Heart; Hospitals; Humans; Kidney diseases; Kidney Diseases - etiology; Kidney Diseases - genetics; Kidney Failure, Chronic - etiology; Kidney Failure, Chronic - genetics; Male; Medicine; Middle Aged; Polymorphism, Single Nucleotide; Population; Public health; Risk factors; Single nucleotide polymorphisms; Statistical methods; Studies; Uromodulin - genetics; White People - genetics; United States; Netherlands; Germany
• ISSN: 1553-7404; 1553-7390; 1553-7404
• DOI: 10.1371/journal.pgen.1002292

Family studies suggest a genetic component to the etiology of chronic kidney disease (CKD) and end stage renal disease (ESRD). Previously, we identified 16 loci for eGFR in genome-wide association studies, but the associations of these single nucleotide polymorphisms (SNPs) for incident CKD or ESRD are unknown. We thus investigated the association of these loci with incident CKD in 26,308 individuals of European ancestry free of CKD at baseline drawn from eight population-based cohorts followed for a median of 7.2 years (including 2,122 incident CKD cases defined as eGFR <60ml/min/1.73m(2) at follow-up) and with ESRD in four case-control studies in subjects of European ancestry (3,775 cases, 4,577 controls). SNPs at 11 of the 16 loci (UMOD, PRKAG2, ANXA9, DAB2, SHROOM3, DACH1, STC1, SLC34A1, ALMS1/NAT8, UBE2Q2, and GCKR) were associated with incident CKD; p-values ranged from p = 4.1e-9 in UMOD to p = 0.03 in GCKR. After adjusting for baseline eGFR, six of these loci remained significantly associated with incident CKD (UMOD, PRKAG2, ANXA9, DAB2, DACH1, and STC1). SNPs in UMOD (OR = 0.92, p = 0.04) and GCKR (OR = 0.93, p = 0.03) were nominally associated with ESRD. In summary, the majority of eGFR-related loci are either associated or show a strong trend towards association with incident CKD, but have modest associations with ESRD in individuals of European descent. Additional work is required to characterize the association of genetic determinants of CKD and ESRD at different stages of disease progression.